| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/31/1992 | US5101039 Azabicycloamino carboxylic acid intermediates |
| 03/31/1992 | US5100913 Novel sulfonylphenyl-β-D-thioxylosides, their method of preparation and their use in therapeutics |
| 03/31/1992 | US5100884 8,9-aneallated-1,2,3,4-tetrahydro-β-carboline derivatives |
| 03/31/1992 | US5100875 Novel peptides having plateler aggregation inhibitory activity |
| 03/31/1992 | US5100592 Heated rotary spreaders, two feed streams, melting and coating powders |
| 03/29/1992 | WO1992006116A1 Hybrid growth factors |
| 03/29/1992 | WO1992006085A1 Phenylpyridinol derivatives as medicaments |
| 03/29/1992 | WO1992005786A1 Ibuprofen-diuretic combinations |
| 03/29/1992 | CA2092565A1 Ibuprofen-diuretic combinations |
| 03/29/1992 | CA2091989A1 Phenylpyridinol derivatives as medicaments |
| 03/29/1992 | CA2069746A1 Hybrid growth factors |
| 03/28/1992 | CA2052069A1 Fibrinogen receptor antagonists |
| 03/28/1992 | CA2052057A1 Fibrinogen receptor antagonists |
| 03/28/1992 | CA2052043A1 Fibrinogen receptor antagonists |
| 03/27/1992 | CA2052198A1 Therapeutically active peptides and pseudopeptides in the blood clotting cascade, their preparation process and the pharmaceutical compositions containing such |
| 03/25/1992 | EP0476994A1 7-Oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| 03/25/1992 | EP0476935A1 New indol and indoline derivatives |
| 03/25/1992 | EP0476646A1 Calcium uptake inhibitors |
| 03/25/1992 | EP0476645A1 Calcium uptake inhibitors |
| 03/25/1992 | EP0476038A1 Chemical products. |
| 03/25/1992 | CA2052022A1 Peptides having thrombospondin-like activity and their therapeutic use |
| 03/24/1992 | US5099034 Nervous system and cardiovascular disorders |
| 03/24/1992 | US5098919 Liver disease |
| 03/24/1992 | US5098722 Method of manufacturing iron-fortified beverage |
| 03/24/1992 | CA1297816C Platelet function inhibiting monoclonal antibody fragment |
| 03/24/1992 | CA1297791C Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator |
| 03/22/1992 | WO1992004912A1 Composition for inducing granulocyte production or b cell production in peripheral blood |
| 03/20/1992 | CA2050054A1 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| 03/19/1992 | WO1992004378A1 Recombinant agents affecting thrombosis |
| 03/19/1992 | WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy |
| 03/19/1992 | WO1992004334A1 Compounds |
| 03/19/1992 | WO1992004332A1 Imidazole derivatives, their preparation and pharmaceutical compositions |
| 03/19/1992 | WO1992004331A1 Substituted 2 imidazolone derivatives, their preparation and pharmaceutical compositions |
| 03/19/1992 | WO1992004330A1 Substituted imidazoles, their preparation and pharmaceutical compositions |
| 03/19/1992 | WO1992002612A3 Tissue plasminogen activator variants with decreased clearance |
| 03/19/1992 | CA2090410A1 Antithrombosis agents |
| 03/18/1992 | EP0475394A2 Rat C-type natriuretic peptide cDNA and precursor protein |
| 03/18/1992 | EP0475383A2 Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient |
| 03/18/1992 | EP0475291A1 A novel biologically active peptide derived from chicken (chicken CNP) |
| 03/18/1992 | EP0475290A1 A novel biologically active peptide derived from frog (frog CNP) |
| 03/18/1992 | EP0475204A2 Heteroazepinoid amides |
| 03/18/1992 | CN1015893B 1,3-dioxanes |
| 03/17/1992 | US5097019 Pharmaceutical containing tissue protein pp4, a process for the preparation of pp4 and for the pasteurization thereof, and the use of pp4 |
| 03/17/1992 | US5096897 Antithrombotic substituted cycloalkano(b)dihydroindole- and -indole-sulphonamides |
| 03/17/1992 | US5096892 Arylsulfatase inhibition and potentiation of angiostatic steroids and heparin |
| 03/17/1992 | US5096708 Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides |
| 03/17/1992 | CA1297634C Anticoagulating substance and preparation process thereof |
| 03/12/1992 | WO1992004349A1 Therapeutic agents |
| 03/12/1992 | CA2088777A1 Therapeutic agents |
| 03/11/1992 | EP0474580A2 Use of 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders |
| 03/11/1992 | EP0474456A2 Oligopeptides exhibiting selective inhibiting effect upon the proliferation of hemopoietic cells |
| 03/11/1992 | EP0474109A1 New 5-benzyl-substituted benzimidazolin-2-thion derivatives and process for their preparation |
| 03/11/1992 | EP0473673A1 Method for protection from azt side effects and toxicity |
| 03/10/1992 | US5095004 Fluorine containing atrial natriuretic peptides |
| 03/10/1992 | US5094953 Human tissue plasminogen activator variants |
| 03/10/1992 | CA1297011C Method of producing a factor viii (ahf) containing fraction |
| 03/10/1992 | CA1297010C Combination of t-pa and a prostaglandin |
| 03/05/1992 | WO1992004031A1 Preservation of blood, tissues and biological fluids |
| 03/05/1992 | WO1992003153A1 Hemoglobin-oligomer based composition and method to make same |
| 03/05/1992 | WO1992003151A1 Uses of recombinant colony stimulating factor-1 |
| 03/05/1992 | WO1992001794A3 Ancrod-like proteins, their preparation and their use |
| 03/05/1992 | WO1991019707A3 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
| 03/05/1992 | CA2648350A1 Superior thrombomodulin analogs for pharmaceutical use |
| 03/05/1992 | CA2072871A1 Preservation of blood, tissues and biological fluids |
| 03/05/1992 | CA2067241A1 Hemoglobin-oligomer based composition and method to make same |
| 03/04/1992 | EP0473564A1 Anticoagulant combination of laci and sulfated polysaccharides |
| 03/04/1992 | EP0473024A1 Heterocyclic substituted cycloalkano(b)-indolesulfonamides |
| 03/04/1992 | CN1059143A Pyrazolopyridine compound and process for prepn. thereof |
| 03/03/1992 | US5093340 Lipoxygenase enzyme inhibitors, antithrombolytic agents |
| 03/03/1992 | US5093339 Anticoagulant, hypotensive, antiangina, antiasthma, antiulcer, anti-platelet activating factor |
| 03/03/1992 | US5093325 Combination preparation having antithrombotic action |
| 03/03/1992 | US5093322 Tick-derived amblyommin and method of antithrombin therapy |
| 03/01/1992 | CA2050268A1 Hetrazepinoid amides |
| 02/28/1992 | WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1992 | CA2090469A1 Ligand for the c-kit receptor and methods of use thereof |
| 02/26/1992 | EP0472449A2 Substituted sulfonamides, processes for their preparation and medicines containing them |
| 02/26/1992 | EP0472325A2 Acid addition salts of an optically active alaninanilide compound and pharmaceutical compositions containing the same |
| 02/26/1992 | EP0471759A1 HIGH LEVEL EXPRESSION OF FUNCTIONAL HUMAN PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) IN $i(E. COLI) |
| 02/26/1992 | EP0471750A1 Heterocyclic n-oxide derivatives of substituted benzo 5,6]cycloheptapyridines, compositions and methods of use |
| 02/26/1992 | EP0218712B1 Novel procoagulant proteins |
| 02/25/1992 | US5091398 Substituted 1,2,3,4-oxatriazolium-5-olates, a process for their preparation and their use |
| 02/25/1992 | US5091363 Mixture of Factor viii, antitnrombin, phospholipid, calcium! compound, and factor ix |
| 02/20/1992 | WO1992002612A2 Tissue plasminogen activator variants with decreased clearance |
| 02/20/1992 | WO1992002513A1 Heterocyclic compounds |
| 02/20/1992 | WO1991019734A3 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 02/19/1992 | EP0471651A2 Peptide boronic acid derivatives having protease inhibiting activity |
| 02/19/1992 | EP0471259A1 Phenylsulfonamid substituted pyridinealken- and aminooxyalkan-carboxylic-acid derivatives |
| 02/19/1992 | CN1058779A Carbostyril derivatives and pharmaceutical composition containing the same |
| 02/19/1992 | CN1015541B Process for preparing (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
| 02/18/1992 | WO1992003434A1 Therapeutic agents |
| 02/18/1992 | US5089496 Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
| 02/18/1992 | US5089409 Increasing proportion of neutral oligosaccharides in the tissue plasminogen glycoproteins |
| 02/18/1992 | US5089274 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
| 02/18/1992 | US5089265 Mixture with product of lactobacillus fermentation of rice bran; for deodorizing |
| 02/18/1992 | CA2087710A1 Therapeutic agents |
| 02/18/1992 | CA1296011C ¬(phenyl-sulphamoyl or sulphonamido)- 1,2,3,4-tetrahydroisoquinoline-2-yl| alkyl acid |
| 02/18/1992 | CA1296009C ¬(2-imidozol-l-yl ethylthio|-benzoic acid derivative |
| 02/18/1992 | CA1296002C Substituted thiazoles and oxazoles, medicaments containing these compounds, and processes for their preparation |
| 02/16/1992 | WO1992003423A1 Benzimidazole derivatives, process for their preparation and application |
| 02/14/1992 | CA2048953A1 Borolysine peptidomimetics |